These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16960411)

  • 1. Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure.
    Akdeniz B; Guneri S; Savas IZ; Aslan O; Baris N; Badak O; Kirimli O; Göldeli O
    Int Heart J; 2006 Jul; 47(4):565-73. PubMed ID: 16960411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure.
    Yildirir A; Sade E; Tokgozoglu L; Oto A
    Eur J Heart Fail; 2001 Dec; 3(6):717-21. PubMed ID: 11738224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy.
    Oflaz MB; Balli S; Kibar AE; Ece I; Akdeniz C; Tuzcu V
    Med Sci Monit; 2013 May; 19():366-72. PubMed ID: 23686300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.
    Bullinga JR; Alharethi R; Schram MS; Bristow MR; Gilbert EM
    J Card Fail; 2005 Dec; 11(9):693-9. PubMed ID: 16360965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
    Aygul N; Ozdemir K; Duzenli MA; Aygul MU
    Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy].
    Hoffmann J; Grimm W; Menz V; Hufnagel G; Maisch B
    Z Kardiol; 1999 Sep; 88(9):653-60. PubMed ID: 10525927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.
    Mortara A; La Rovere MT; Pinna GD; Maestri R; Capomolla S; Cobelli F
    J Am Coll Cardiol; 2000 Nov; 36(5):1612-8. PubMed ID: 11079666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol on heart rate dynamics in patients with congestive heart failure.
    Ridha M; Mäkikallio TH; Lopera G; Pastor J; de Marchena E; Chakko S; Huikuri HV; Castellanos A; Myerburg RJ
    Ann Noninvasive Electrocardiol; 2002 Apr; 7(2):133-8. PubMed ID: 12049685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol can restore the multifractal properties of heart beat dynamics in patients with advanced congestive heart failure.
    Chiu KM; Chan HL; Chu SH; Lin TY
    Auton Neurosci; 2007 Mar; 132(1-2):76-80. PubMed ID: 17157564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
    Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carvedilol on ventricular arrhythmias.
    Senior R; Müller-Beckmann B; DasGupta P; van der Does R; Lahiri A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S117-21. PubMed ID: 1378137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation.
    Pamboukian SV; Aminbakhsh A; Thompson CR; Amin H; Mortimer S; D'yachkova Y; Ignaszweski AP
    Clin Transplant; 1999 Oct; 13(5):426-31. PubMed ID: 10515224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy.
    Piccirillo G; Quaglione R; Nocco M; Naso C; Moisè A; Lionetti M; Di Carlo S; Marigliano V
    Am J Cardiol; 2002 Nov; 90(10):1113-7. PubMed ID: 12423713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: is there a difference in the elderly?
    Rocha RM; Silva GV; Perin EC; Gerk AR; Gouvea EP; Santos VM; Filho FM; de Albuquerque DC
    Tex Heart Inst J; 2003; 30(3):176-9. PubMed ID: 12959198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
    Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
    Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
    Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
    Nul D; Zambrano C; Diaz A; Ferrante D; Varini S; Soifer S; Grancelli H; Doval H;
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):125-34. PubMed ID: 16025231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
    Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.